Acute Lung Injury Associated with Docetaxel and Bevacizumab

Clinical Oncology

Volumn 19, Issue 10, 2007, Pages 803-805

  Prat, A ^a   Martinez P ^a   Serrano, C ^a   Montero, M A ^a   Andreu, J ^a   Cortes J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZITHROMYCIN; BEVACIZUMAB; CEFEPIME; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; HEMOGLOBIN; PREDNISONE; RANITIDINE;

ACUTE LUNG INJURY; AGED; BLOOD PRESSURE; BREAST CANCER; BREATHING RATE; CARBON DIOXIDE TENSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; EMERGENCY HEALTH SERVICE; FEMALE; FEVER; HUMAN; INTERSTITIAL PNEUMONIA; LETTER; LEUKOCYTE COUNT; LIVER INJURY; LIVER METASTASIS; LUNG AUSCULTATION; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MEDIASTINUM LYMPH NODE; MULTIPLE CYCLE TREATMENT; NEUTROPHIL; OXYGEN TENSION; PRIORITY JOURNAL; PULSE RATE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; TREATMENT DURATION;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; NEOPLASM METASTASIS; RESPIRATORY DISTRESS SYNDROME, ADULT; TAXOIDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35549008022     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.08.010     Document Type: Letter

References (5)

1. Kouroussis C., Mavroudis D., Kakolyris S., et al. High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study. Lung Cancer 44 (2004) 363-368
2. Read W., Mortimer J., and Picus J. Severe interstitial pneumonitis associated with docetaxel administration. Cancer 94 (2002) 847-853
3. Medford A.R.L., and Millar A.B. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?. Thorax 61 (2006) 621-626
4. Behrens R., Gulley J., and Dahut W. Pulmonary toxicity during prostate cancer treatment with docetaxel and thalidomide. Am J Ther 10 (2003) 228-232
5. Heymach J.V., Johnson B.E., Prager D., et al. A phase II trial of ZD6474 plus docetaxel in patients with previously treated NSCLC: follow-up results. J Clin Oncol (Meeting Abstracts) 24 (2006) 7016-7017